Illumina, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (35)

Latest Posts

About This Stock More About This Stock
Winners Of Q1 Earnings: 5 Best ETF Charts
Article By: Sweta Killa
Sunday, May 27, 2018 4:01 PM EDT
several equity ETFs have impressed with their performances and generated handsome returns over the trailing one month even after being hit by the trade worries and geopolitical tensions. Here are five ETFs that buoyed up on robust earnings results.
In this article: PTH, SPY, PSCE, GAMR, ARKK, ILMN, SSYS, TSLA, EDIT, NTLA, MKSI, FTXL
Read
Week In Review: Grail, An Oncology Diagnostics Company, Taps China Investors For $300 Million
Article By: ChinaBio® Today
Saturday, May 26, 2018 4:42 PM EDT
Grail, a Hong Kong-US oncology diagnostics company, announced a $300 million C financing. The company is sequencing large populations of people -- some with cancer, some without -- to discover an early blood-based diagnostic test for cancer.
In this article: ILMN, KPTI
Read
Week In Review: Grail Plans $500 Million Hong Kong IPO For Cancer Diagnostics
Article By: ChinaBio® Today
Saturday, March 3, 2018 5:10 PM EDT
Grail, a US spinout from Illumina that is developing blood-based cancer detection tests, is considering a $500 million Hong Kong IPO. Last year, Grail completed a $900 million Series B fundraising, the largest ever.
In this article: ILMN
Read
4 Biotech Stocks That Are Potentially Setting A Major Double Top
Article By: Taki Tsaklanos
Saturday, February 24, 2018 5:20 PM EDT
The following four leading biotech stocks have shown signs of fatigue and look set for mid-term bearish outlook unless a very strong buy signal would emerge in the very short term.
In this article: ILMN, REGN, BIIB, CELG
Read
Week In Review: China Life Science Starts 2018 With $2 Billion Week
Article By: ChinaBio® Today
Saturday, January 6, 2018 5:40 PM EDT
Perennial Real Estate Holdings announced a $1.2 billion joint venture that will acquire and develop healthcare centers in China. It plans to concentrate on integrated mixed-use developments that are connected to China high speed railway stations.
In this article: GSK, ARRY, INO, ILMN
Read

PARTNER HEADLINES

Latest Tweets for $ILMN

No tweets yet!